基层医疗可维持降尿酸治疗的长期持续性与依从性:一项概念验证研究的5年随访
5年治疗持续性为90.7%(95%CI 81.4, 91.6),85.3%的应答者自报每周服药≥6天;65例参加访视者平均血尿酸为292.8 μmol/l(s.d. 97.2)。结论认为包含个体化患者教育和参与治疗决策的初始治疗模式在基层医疗中可维持极佳的依从性和持续性。
要点
- 5年降尿酸治疗持续性达90.7%,85.3%应答者每周服药≥6天。
- 参加访视者平均血尿酸292.8 μmol/l(s.d. 97.2)。
- 包含个体化教育和参与治疗决策的初始模式值得推广。
核心结论
- 包含个体化患者教育和参与治疗决策的初始治疗,在治疗责任转交全科医生后,仍可维持降尿酸治疗超过4年的极佳依从性和持续性。
主要发现
- 5年降尿酸治疗持续性为90.7%(95%CI 81.4, 91.6)。
- 85.3%的应答者自报每周服用降尿酸治疗≥6天。
- 65例参加研究访视者的平均血尿酸为292.8 μmol/l(s.d. 97.2)。
临床怎么用
- 在基层医疗中,采用包含个体化患者教育和参与治疗决策的初始治疗模式,可能有助于长期维持痛风患者的降尿酸治疗依从性和持续性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the persistence and adherence on urate-lowering treatment (ULT) in primary care 5 years after an initial nurse-led treatment of gout. METHODS: One hundred gout patients initiated on up-titrated ULT between March and July 2010 were sent a questionnaire that elicited information on current ULT, reasons for discontinuation of ULT if applicable, medication adherence and generic and disease-specific quality-of-life measures in 2015. They were invited for one visit at which height and weight were measured and blood was collected for serum uric acid measurement. RESULTS: Seventy-five patients, mean age 68.13 years ( s . d . 10.07) and disease duration 19.44 years ( s . d . 13), returned completed questionnaires. The 5-year persistence on ULT was 90.7% (95% CI 81.4, 91.6) and 85.3% of responders self-reported taking ULT ⩾6 days/week. Of the 65 patients who attended the study visit, the mean serum uric acid was 292.8 μmol/l ( s . d . 97.2). CONCLUSION: An initial treatment that includes individualized patient education and involvement in treatment decisions results in excellent adherence and persistence on ULT >4 years after the responsibility of treatment is taken over by the patient's general practitioner, suggesting that this model of gout management should be widely adopted.
引用
- Abhishek A, Jenkins W, La-Crette J, et al. Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study. Rheumatology (Oxford). 2017. PMID: 28082620. doi:10.1093/rheumatology/kew395
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。